Recommendations	Strength of recommendation	Quality of evidence
Antifungal therapy is indicated in patients with CAPA	Strong	Low
We recommend to follow national or international guidelines on antifungal therapy of invasive aspergillosis	Strong	Low
We recommend to consider empirical therapy for CAPA in patients in who(m) a BAL has been performed and BAL GM/PCR results are pending	Weak	Very low
In patients with a negative BAL GM, discontinuation of empirical antifungal therapy is recommended	Weak	Very low
Therapeutic drug monitoring (TDM) is recommended in critically ill CAPA patients receiving triazole therapy	Strong	Low